AI cannot replace clinical trials soon, warns Moderna co-founder Noubar Afeyan

Business News Today: Latest Business News, Finance News ·
India

Afeyan cautioned against overhyping AI’s ability to cure diseases such as cancer, arguing that scientific progress must be accompanied by greater humility about what researchers understand about human physiology.

Read original article on Business News Today: Latest Business News, Finance News →

Related news